Haryana Medicines Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.12 M
- Company Age 26 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.10 M
About Haryana Medicines
Haryana Medicines Pvt Ltd (HMPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 March 1998 and has a history of 26 years and 11 months. Its registered office is in Rohtak, Haryana, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.12 M.
The company has closed loans amounting to ₹1.10 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Vijay Verma, Geeta Arora, and Ritu Arora serve as directors at the Company.
Company Details
-
Location
Rohtak, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24232HR1998PTC033874
-
Company No.
033874
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Mar 1998
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Haryana Medicines?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijay Verma
|
Director | 10-Aug-2022 | Current |
|
Geeta Arora
|
Director | 03-Mar-1998 | Current |
|
Ritu Arora
|
Additional Director | 23-Sep-2023 | Current |
Financial Performance of Haryana Medicines.
Haryana Medicines Pvt Ltd, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Haryana Medicines?
In 2017, Haryana Medicines had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
J S Treads Pvt LtdVijay Verma is a mutual person
Charges (Loans)
₹0
₹1.10 M
Charges Breakdown by Lending Institutions
- Indian Overseas Bank : 0.11 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2010 | Indian Overseas Bank | ₹1.00 M | Satisfied |
| 30 Aug 2000 | Indian Overseas Bank | ₹0.10 M | Satisfied |
How Many Employees Work at Haryana Medicines?
Unlock and access historical data on people associated with Haryana Medicines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Haryana Medicines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Haryana Medicines's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
